Cargando…
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure
BACKGROUND: Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in definitive heart failure (HF), but there is little information about changes in sACE2 activity in hypertension with imminent heart failure and in reverse remodeling. METHODS, FINDINGS: Patients...
Autores principales: | Úri, Katalin, Fagyas, Miklós, Mányiné Siket, Ivetta, Kertész, Attila, Csanádi, Zoltán, Sándorfi, Gábor, Clemens, Marcell, Fedor, Roland, Papp, Zoltán, Édes, István, Tóth, Attila, Lizanecz, Erzsébet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972189/ https://www.ncbi.nlm.nih.gov/pubmed/24691269 http://dx.doi.org/10.1371/journal.pone.0087845 |
Ejemplares similares
-
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition
por: Fagyas, Miklós, et al.
Publicado: (2014) -
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases
por: Fagyas, Miklós, et al.
Publicado: (2014) -
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human
por: Fagyas, Miklós, et al.
Publicado: (2014) -
Circulating ACE2 activity correlates with cardiovascular disease development
por: Úri, Katalin, et al.
Publicado: (2016) -
Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients
por: Fagyas, Miklós, et al.
Publicado: (2021)